Pharmacielo Ltd
XTSX:PCLO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Pharmacielo Ltd
XTSX:PCLO
|
CA |
|
Atco Ltd
TSX:ACO.Y
|
CA |
|
Huafa Property Services Group Co Ltd
HKEX:982
|
HK |
Balance Sheet
Balance Sheet Decomposition
Pharmacielo Ltd
Pharmacielo Ltd
Balance Sheet
Pharmacielo Ltd
| Aug-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
0
|
14
|
9
|
5
|
0
|
0
|
0
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
0
|
14
|
9
|
5
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
2
|
1
|
1
|
1
|
1
|
1
|
|
| Accounts Receivables |
0
|
1
|
0
|
0
|
1
|
0
|
0
|
|
| Other Receivables |
0
|
1
|
1
|
0
|
0
|
1
|
0
|
|
| Inventory |
0
|
4
|
1
|
2
|
2
|
2
|
1
|
|
| Other Current Assets |
0
|
0
|
1
|
1
|
1
|
0
|
0
|
|
| Total Current Assets |
0
|
20
|
13
|
9
|
4
|
3
|
2
|
|
| PP&E Net |
0
|
29
|
31
|
26
|
21
|
19
|
16
|
|
| PP&E Gross |
0
|
29
|
31
|
26
|
21
|
19
|
16
|
|
| Accumulated Depreciation |
0
|
2
|
4
|
5
|
5
|
8
|
9
|
|
| Intangible Assets |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Goodwill |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
1
|
1
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
0
N/A
|
50
+24 010%
|
44
-12%
|
36
-18%
|
25
-30%
|
22
-11%
|
19
-17%
|
|
| Liabilities | ||||||||
| Accounts Payable |
0
|
3
|
12
|
8
|
6
|
6
|
6
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
1
|
16
|
18
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
0
|
3
|
12
|
8
|
7
|
21
|
23
|
|
| Long-Term Debt |
0
|
1
|
4
|
8
|
12
|
3
|
5
|
|
| Other Liabilities |
0
|
0
|
1
|
0
|
0
|
0
|
0
|
|
| Total Liabilities |
0
N/A
|
5
+20 742%
|
18
+276%
|
17
-6%
|
19
+13%
|
24
+28%
|
28
+17%
|
|
| Equity | ||||||||
| Common Stock |
0
|
117
|
139
|
158
|
162
|
167
|
169
|
|
| Retained Earnings |
0
|
71
|
110
|
133
|
147
|
163
|
173
|
|
| Other Equity |
0
|
0
|
3
|
6
|
9
|
5
|
6
|
|
| Total Equity |
0
N/A
|
45
+24 396%
|
26
-42%
|
19
-26%
|
6
-67%
|
2
N/A
|
9
-465%
|
|
| Total Liabilities & Equity |
0
N/A
|
50
+24 010%
|
44
-12%
|
36
-18%
|
25
-30%
|
22
-11%
|
19
-17%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
0
|
99
|
139
|
149
|
155
|
169
|
188
|
|